FOCIS New Investigator Travel Awards (2004-2008)

描述(由申请人提供)：这项拨款申请是为来自美国的新研究人员(博士后研究员、博士后研究员和初级教员)参加临床免疫学会联合会(FOCIS)年会提供的五十(50)项旅行奖励，每项1,500美元，总计75,000美元，年增长率为5%。这一拨款申请仅占Focis旅游奖资金的50%。将从制药和生物技术公司那里寻求额外的资金。 FOCIS年度会议提供了一个科学论坛，以促进随着临床免疫学学科的发展而理解和治疗基于免疫的疾病所需的跨学科方法。这一进化反映了许多疾病的共同病理生理学，包括：自身免疫性疾病、癌症、过敏/哮喘、传染病、免疫缺陷和移植排斥。虽然临床医生必须与与他们自己的专业相关的疾病保持联系，但最近在诊断和治疗这些不同疾病方面取得的进展背后的免疫学科学是多学科的，跨越了标准的临床边界。FOCIS年会的最终目标是更好地了解临床免疫学的共同病理生理学基础，以及这些新的关系所建议的新的治疗方法，包括在治疗中越来越广泛地使用生物制剂。FOCIS年会为新的研究人员提供了一个机会，了解基础科学模型的哪些方面的突破将进入临床，以及临床疗法如何应用于完全不同的领域。 除了突出该领域最好的科学之外，FOCIS年度会议还为培养科学家和从业人员以及相关生物技术和制药行业的代表提供了一个孵化器，他们的共同支持对这次会议的成功是非常宝贵的。每天包括海报和口头摘要演示，让年轻的科学家和资深研究人员有机会展示和批评他们的工作。通过相互分享发现，代表们获得了研究和应用科学的新想法，这些学科本来不会在疾病或器官专题会议上接触到。FOCIS年度会议是新研究人员了解将基础免疫学实验室与临床实践联系起来的不同翻译方法的理想论坛。除了鼓励新调查人员的参与外，FOCIS还认识到广泛人口统计参与的重要性。已尽一切努力在焦点指导委员会和年度会议的科学方案中纳入不同的代表。在第三届FOCUS年会上，36%的与会者是女性，25%是新调查人员，25%是少数民族。

DESCRIPTION (provided by applicant): This grant request is for fifty (50) Travel Awards of $1,500 each for a total of $75,000, increasing by 5% annually, for new investigators (pre-doctoral fellows, post-doctoral fellows and junior faculty members) from the United States to attend the Federation of Clinical Immunology Societies (FOCIS) annual meeting. This grant request accounts for only 50% of the funding for FOCIS Travel Awards. Additional funding will be solicited from pharmaceutical and biotechnology companies. The FOCIS annual meeting provides a scientific forum to foster the cross-disciplinary approach required to understand and treat immune-based diseases as the discipline of clinical immunology evolves. The evolution is a reflection of the shared pathophysiology of many diseases, including: autoimmune diseases, cancer, allergy/asthma, infectious diseases, immune deficiency, and transplant rejection. While clinicians necessarily remain linked to diseases associated with their own specialty, the immunological sciences underlying recent advances in diagnosing and treating these diverse diseases are multidisciplinary and cut across standard clinical boundaries. The ultimate goal of the FOCIS annual meeting is to create a better understanding of the shared pathophysiological underpinnings of clinical immunology and the new therapeutic approaches suggested by these novel relationships, including the increasingly widespread use of biologics in therapy. The FOCIS annual meeting offers new investigators an opportunity to understand where breakthroughs in basic science models are coming into the clinic, and how clinical therapies can be applied in completely different fields. In addition to highlighting the best science in the field, the FOCIS annual meeting is an incubator for developing scientists and practitioners alike to meet with one another along with representatives of the relevant biotechnology and pharmaceutical industry whose combined support is invaluable to the success of this meeting. Each day includes poster and oral abstract presentations to give young scientists as well as senior investigators the chance to have their work presented and critiqued. By sharing discoveries with one another, delegates acquire new ideas for research and applied science from disciplines to which they would otherwise not be exposed at disease- or organ-specific meetings. The FOCIS annual meeting is an ideal forum for new investigators to learn about the different translational approaches that are bridging the basic immunology laboratories with clinical practice. In addition to encouraging the participation of new investigators, FOCIS recognizes the importance of participation from a wide range of demographics. Every effort has been made to include a diverse representation within the FOCIS Steering Committee and the annual meeting's scientific program. At the third annual FOCIS meeting, 36% of the meeting attendees were woman, 25% were new investigators, and 25% were minority.